Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Clinical Characteristics and Acute Management of Pediatric Pulmonary Embolism

Kristina Wagner, Leslie J. Raffini, Hilary Whitworth

Blood (2022) 140 (Supplement 1): 2801–2802.

https://doi.org/10.1182/blood-2022-164830

Published: 2022

Journal Articles

Emicizumab and Females with Hemophilia A: Case Series from ATHN 7

Michael Recht, Nabil Daoud, Lucy Lee, Paul Morton, Leslie J. Raffini

Blood (2022) 140 (Supplement 1): 2745–2746.

https://doi.org/10.1182/blood-2022-157754

Published: 2022

Journal Articles

Reduced Dosing Frequency Following a Switch to Rix-FP for the Treatment of Hemophilia B: Results from the Athn 2 Study

Janna Journeycake, Dunlei Cheng, Tammuella Chrisentery-Singleton, Vidhi Desai, Annette von Drygalski, Carol Fedor, Nikki Hirsh, Birju Patel, Leslie J. Raffini, Michael Recht, Robert F. Sidinio, Jr., Michael Wang, Xiang Zhang, Ellis J. Neufeld

Blood (2021) 138 (Supplement 1): 1039.

https://doi.org/10.1182/blood-2021-144617

Published: 2021

Journal Articles

Validating Direct Oral Anticoagulants (DOAC) for Use in Children By the Throm-PED Doac Registry of the International Pediatric Thrombosis Network

Susanne Holzhauer, Christoph Male, Paul Monagle, Mohammadreza Bordbar, Heleen van Ommen, Leslie J. Raffini

Blood (2021) 138 (Supplement 1): 1063.

https://doi.org/10.1182/blood-2021-151005

Published: 2021

Journal Articles

The Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study

Craig D. Seaman, Margaret V. Ragni, Peter A. Kouides, Eric H. Kraut, Rajiv K. Pruthi, Leslie J. Raffini, Jonathan C. Roberts, Annette von Drygalski, Daniel B. Bellissimo, Maria M Brooks

Blood (2021) 138 (Supplement 1): 1044.

https://doi.org/10.1182/blood-2021-152755

Published: 2021

Journal Articles

Hemophilia Natural History Study (ATHN 7): Safety of Current Therapies for People with Hemophilia A or B

Tyler W. Buckner, Shannon L Carpenter, Nabil Daoud, Nikki Hirsh, Thomas W. McLean, Carrie O'Neill, Leslie J. Raffini, Ayesha Zia, Michael Recht

Blood (2021) 138 (Supplement 1): 2105.

https://doi.org/10.1182/blood-2021-146726

Published: 2021

Journal Articles

Athn 15: Characterizing the Real-World Use of Direct Oral Anticoagulants in Pediatric Patients - Interim Analysis

Jennifer G. Davila, MD, Fernando F. Corrales-Medina, MD, Dunlei Cheng, PhD, Leslie J. Raffini, MD, Courtney D Thornburg, MD, Crystal Watson, BS

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-137113

Published: 2020

Journal Articles

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Tyler W. Buckner, MDMSc, Shannon L Carpenter, MD, Stacy E. Croteau, MD, Adam Cuker, MDMS, Nabil Daoud, MA, Christine L Kempton, MDMSc, Lynn M Malec, MD, Thomas W. McLean, MD, Leslie J. Raffini, MD, Janice M Staber, MD, Michael Wang, MD, Crystal Watson, BS, Ayesha Zia, MD, Michael Recht, MD PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137696

Published: 2020

Journal Articles

Characterizing the Use of Direct Oral Anticoagulants in Children Using the American Thrombosis and Hemostasis Network Dataset (ATHNdataset)

Jennifer G. Davila, MD, Dunlei Cheng, PhD, Leslie J. Raffini, MD, Courtney D. Thornburg, MD, Fernando F. Corrales-Medina, MD

Blood (2019) 134 (Supplement_1): 1156.

https://doi.org/10.1182/blood-2019-128324

Published: 2019

Journal Articles

Real-World Use of Emicizumab in Patients with Hemophilia with and without Inhibitors

Isabella McCary, BS, Christine Guelcher, PPCNP-BC, Jan Kuhn, BA, BSN, MSN, Regina Butler, RN-BC, Gita Massey, Michael F. Guerrera, MD, Lance Ballester, MS, Leslie J. Raffini, MD

Blood (2019) 134 (Supplement_1): 1137.

https://doi.org/10.1182/blood-2019-122569

Published: 2019

Journal Articles

Peri-Procedural Management and Outcomes of Patients with Hemophilia on Emicizumab Prophylaxis

Isabella McCary, BS, Christine Guelcher, PPCNP-BC, Jan Kuhn, BA, BSN, MSN, Regina Butler, RN-BC, Michael F. Guerrera, MD, Gita Massey, Leslie J. Raffini, MD

Blood (2019) 134 (Supplement_1): 2396.

https://doi.org/10.1182/blood-2019-126944

Published: 2019

Journal Articles

Children with CVC-VTE: A Very High Risk Group for Recurrent Thrombosis

Aditi B Kamdar, MD, Leslie J Raffini, MD MSCE, Char M Witmer, MDMSCE

Blood (2017) 130 (Supplement 1): 1098.

https://doi.org/10.1182/blood.V130.Suppl_1.1098.1098

Published: 2017

Journal Articles

Practical Application of the Athndataset: Evaluating Uptake of Extended Half-Life Factor Concentrates in Patients with Moderate and Severe Hemophilia

Stacy E. Croteau, MD, Dunlei Cheng, PhD, Alice J. Cohen, MD, Chris E. Holmes, MD PhD, Peter A. Kouides, MD, Leslie J Raffini, MD MSCE, Michael Silvey, DO, Courtney Thornburg, MD, Allison P. Wheeler, MD, Ellis J Neufeld, MD PhD

Blood (2017) 130 (Supplement 1): 23.

https://doi.org/10.1182/blood.V130.Suppl_1.23.23

Published: 2017

Journal Articles

Health-Related Quality of Life and Satisfaction of Children with Severe Hemophilia a Treated with Turoctocog Alfa Pegol (N8-GP)

Susan Kearney, MD, Tan P Pham, MPH, MS, Johan E Adalsteinsson, Andrea Landorph, Leslie J Raffini, MD MSCE

Blood (2017) 130 (Supplement 1): 2136.

https://doi.org/10.1182/blood.V130.Suppl_1.2136.2136

Published: 2017

Journal Articles

Novel Correlation between B Cell Survival Cytokines and Inhibitors in Hemophilia A

Bhavya S Doshi, MD, Simon F Lacey, PhD BS, Fang Chen, PhD, Leslie J Raffini, MD MSCE, Valder R Arruda, MD PhD

Blood (2017) 130 (Supplement 1): 3677.

https://doi.org/10.1182/blood.V130.Suppl_1.3677.3677

Published: 2017

Journal Articles

Zymogen-like FXa Variant As a Short-Acting Warfarin Reversal Agent: Pre-Clinical Evaluation and Mechanism of Action

Lindsey A. Greene, MD, Nabil K. Thalji, BS, Leslie J. Raffini, MD, Rodney M. Camire, PhD

Blood (2014) 124 (21): 4262.

https://doi.org/10.1182/blood.V124.21.4262.4262

Published: 2014

Journal Articles

Lack Of Anti-Xa Assay Standardization Results In Significant Dose Variation In Neonates and Children Receiving Enoxaparin

Lindsey A. Greene, MD, Connie Law, Rh.D, Mike Jung, B.S., Sara Walton, B.S., Leslie J. Raffini, MD

Blood (2013) 122 (21): 2379.

https://doi.org/10.1182/blood.V122.21.2379.2379

Published: 2013

Journal Articles

Comparison Of Three Post-Thrombotic Assessment Tools In Young Patients With Deep Venous Thrombosis Demonstrates Significant Variability

Jillian Davenport, Sarah Iosifescu, Leslie J. Raffini, MD

Blood (2013) 122 (21): 1129.

https://doi.org/10.1182/blood.V122.21.1129.1129

Published: 2013

Journal Articles

Management of Hemophilia and Head Trauma: A Survey of Current Clinical Practice among Pediatric Hematology/Oncology Physicians.

Char M. Witmer, MD, Leslie J. Raffini, MD, Catherine S. Manno, MD

Blood (2007) 110 (11): 3967.

https://doi.org/10.1182/blood.V110.11.3967.3967

Published: 2007

NARROW

Clinical Characteristics and Acute Management of Pediatric Pulmonary Embolism

Emicizumab and Females with Hemophilia A: Case Series from ATHN 7

Reduced Dosing Frequency Following a Switch to Rix-FP for the Treatment of Hemophilia B: Results from the Athn 2 Study

Validating Direct Oral Anticoagulants (DOAC) for Use in Children By the Throm-PED Doac Registry of the International Pediatric Thrombosis Network

The Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study

Hemophilia Natural History Study (ATHN 7): Safety of Current Therapies for People with Hemophilia A or B

Athn 15: Characterizing the Real-World Use of Direct Oral Anticoagulants in Pediatric Patients - Interim Analysis

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Characterizing the Use of Direct Oral Anticoagulants in Children Using the American Thrombosis and Hemostasis Network Dataset (ATHNdataset)

Real-World Use of Emicizumab in Patients with Hemophilia with and without Inhibitors

Peri-Procedural Management and Outcomes of Patients with Hemophilia on Emicizumab Prophylaxis

Children with CVC-VTE: A Very High Risk Group for Recurrent Thrombosis

Practical Application of the Athndataset: Evaluating Uptake of Extended Half-Life Factor Concentrates in Patients with Moderate and Severe Hemophilia

Health-Related Quality of Life and Satisfaction of Children with Severe Hemophilia a Treated with Turoctocog Alfa Pegol (N8-GP)

Novel Correlation between B Cell Survival Cytokines and Inhibitors in Hemophilia A

Zymogen-like FXa Variant As a Short-Acting Warfarin Reversal Agent: Pre-Clinical Evaluation and Mechanism of Action

Lack Of Anti-Xa Assay Standardization Results In Significant Dose Variation In Neonates and Children Receiving Enoxaparin

Comparison Of Three Post-Thrombotic Assessment Tools In Young Patients With Deep Venous Thrombosis Demonstrates Significant Variability

Management of Hemophilia and Head Trauma: A Survey of Current Clinical Practice among Pediatric Hematology/Oncology Physicians.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only